[Colon cancer: molecular markers].
Arnold
C N
CN
Medizinische Universitätsklinik Freiburg. arnold@med1.ukl.uni-freiburg.de
Blum
H E
HE
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000235:genetics; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000235:genetics* / Q000401:mortality / Q000517:prevention & control; D004260:DNA Repair; D004273:DNA, Neoplasm / Q000032:analysis; D005243:Feces / Q000737:chemistry; D005472:Fluorouracil / Q000627:therapeutic use; D016147:Genes, Tumor Suppressor; D011905:Genes, ras; D005819:Genetic Markers; D006801:Humans; D000077146:Irinotecan; D018895:Microsatellite Repeats; D009154:Mutation; D009857:Oncogenes; D016133:Polymerase Chain Reaction; D011379:Prognosis; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D016896:Treatment Outcome; D014407:Tumor Cells, Cultured
D000964:Antimetabolites, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D005819:Genetic Markers; D000077146:Irinotecan; D005472:Fluorouracil; D002166:Camptothecin